Co-Diagnostics, Inc. Adjourns Annual Meeting to Sept 24, 2026

What Happened

• Co-Diagnostics, Inc. announced in an 8-K that its previously scheduled Annual Meeting of Stockholders on September 3, 2026 did not achieve a quorum and was unable to transact business.
• Under the company’s bylaws, the meeting was adjourned by the chair and reconvened for September 24, 2026 at 9:00 a.m. Mountain Time at the company’s offices (2401 S. Foothill Dr, Ste. D, Salt Lake City, Utah 84109).
• The filing notes that stockholder voting at the adjourned meeting will proceed as described in the company’s definitive proxy statement filed with the SEC on July 21, 2026, and that valid proxies submitted previously will remain in effect unless properly changed or revoked before votes are taken.

Key Details

• Original meeting date: September 3, 2026 — adjourned for lack of quorum.
• Reconvened meeting: September 24, 2026 at 9:00 a.m. Mountain Time (Company offices: 2401 S. Foothill Dr, Ste. D, Salt Lake City, UT 84109).
• Prior proxies remain valid for the adjourned meeting unless changed or revoked before voting.
• Reference proxy statement filed with the SEC on July 21, 2026 governs how votes will be cast at the reconvened meeting.

Why It Matters

• For investors, the adjournment delays any stockholder votes (such as elections or approvals described in the proxy) until September 24, 2026.
• If you’ve already submitted a proxy, it will generally still count at the reconvened meeting unless you update or revoke it before votes are taken. If you plan to attend in person or change your vote, act before the reconvened meeting.